CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS
Main Authors: | Mari Paz Serrano-Regal, Inmaculada Alonso-García, Celia Camacho-Toledano, Isabel Machin-Diaz, María Cristina Ortega, Leticia Calahorra, Diego Clemente |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123005742 |
Similar Items
-
Regulatory Cells in Multiple Sclerosis: From Blood to Brain
by: Leticia Calahorra, et al.
Published: (2022-02-01) -
EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
by: Mari Paz Serrano-Regal, et al.
Published: (2023-10-01) -
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
by: Celia Camacho-Toledano, et al.
Published: (2022-11-01) -
MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS
by: María Cristina Ortega, et al.
Published: (2023-10-01) -
Antibodies to myelin lipids in multiple sclerosis
by: M. V. Ivanova, et al.
Published: (2017-02-01)